On Friday, June 12, the Koch Institute for Integrative Cancer Research at MIT will host its 14th annual Summer Symposium, “CANCER COMPLEXITY: Heterogeneity in Tumor Progression and Drug Response.” This one-day symposium at MIT’s Johnson Athletics Center will examine the heterogeneity within tumors that shape their evolutions and allow them to resist treatments. Nearly 1,000 cancer researchers and clinical oncologists will assemble to learn about the latest breakthroughs in overcoming the clinical challenges this complexity creates for cancer diagnostics and therapy.
Members of the press are also invited to join Symposium chair Michael Hemann, Symposium speakers, and Koch Institute Director Tyler Jacks for lunch at MIT’s Stratton Student Center in Twenty Chimneys (room W20-306). All parties will be available for questions.
The full list of Symposium speakers is available at: http://ki.mit.edu/news/symposium.
WHENSymposium: Friday, June 12, 9 a.m.-4:30 p.m. Lunch: Friday, June 12, 12:40 p.m.-2:30 p.m.
WHERESymposiumMIT Johnson Athletics Center (Building W34) 120 Vassar StreetCambridge, MA 02139http://whereis.mit.edu/?go=W34
Speakers’ LunchStratton Student Center (Building W20)84 Massachusetts Avenue, Room 306 Cambridge, MA 02139http://whereis.mit.edu/?go=W20
###
About the Koch Institute for Integrative Cancer ResearchThe Koch Institute for Integrative Cancer Research, a National Cancer Institute-designated Cancer Center, is a state-of-the-art cancer research facility as well as the hub of cancer research on the MIT campus. Completed in 2010, the Koch Institute building allows for the physical co-localization of faculty members from the Department of Biology (formerly in the MIT Center for Cancer Research) with faculty members drawn from a variety of departments in the MIT School of Engineering.
The Koch Institute brings together biologists and chemists along with biological, chemical, mechanical, and materials science engineers, computer scientists, clinicians, and others, to bring fresh perspectives and an interdisciplinary approach to advancing the fight against cancer. This multi-faceted group of investigators is at the core of the Koch Institute’s mission to develop new insights into cancer, as well as new tools and technologies to better treat, diagnose, and prevent the disease. For more information about MIT’s Koch Institute, please visit http://ki.mit.edu.
RSS